Atlas FDA

CRP Immunoturbidimetric reagent. Intended for the quantitative in vitro determination of CRP concentration in serum Cata

FDA device recall Z-1286-2023 · posted 2024-09-30 · Open, Classified

Recall details

Recalling firm
Randox Laboratories
Reason for recall
The Antibody (R2 reagent) is showing a positive bias compared to previous batches on patient samples. Quality Controls do not show the same bias and will be within range
Action taken
Randox UK (manufacturer) extended Urgent Medical Device Removal letter to the US distributor via email on 2/1/23. The distributor contacted the customer via email on 2/6/23. Letter states reason for recall, health risk and action to take: " Discontinue use of and discard any of the above immediately. Provide Randox with photographic evidence of the destruction of the kits. " Review your reagent inventory of these products and assess your laboratories needs for reimbursement for discarded inventory. " Review results generated with the affected batches in line with the clinical profile of the patient. " Discuss the contents of this notice with your Medical Director. " Complete and return the response form 12187-QA to technical.services@randox.com within five working days. If you have any questions or concerns, please contact Randox Technical Services.
Root cause
Under Investigation by firm
Status
Open, Classified
Product code
DCK
Quantity affected
2 kits
Distribution
PA, OH, WV
Date initiated
2023-02-01
Date posted
2024-09-30
Location
Kearneysville, WV

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
C-REACTIVE PROTEIN IMMUNOTURBIDIMETRIC KIT & CRP CALIBRATOR (K953212)Randox Laboratories, Ltd.1995-07-31